DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

ADMA Biologics Q4 EPS $(0.18), Inline, Sales $12M Beat $10.23M Estimate

ADMA Biologics (NASDAQ:ADMA) reported quarterly losses of $(0.18) per share which met the analyst consensus estimate. This is a 53.85 percent increase over losses of $(0.39) per share from the same period last year. The

Benzinga · 03/12/2020 20:27

ADMA Biologics (NASDAQ:ADMA) reported quarterly losses of $(0.18) per share which met the analyst consensus estimate. This is a 53.85 percent increase over losses of $(0.39) per share from the same period last year. The company reported quarterly sales of $12 million which beat the analyst consensus estimate of $10.23 million by 17.30 percent. This is a 195.86 percent increase over sales of $4.056 million the same period last year.